ArticleCancer immunology, immunotherapy : CII2026
Overcoming resistance in CD44-overexpressing myeloma through combination therapy with ATRA, bortezomib, and NK cells.
Van-Tan Nguyen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.